A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache

Pain Digest

Volumn 9, Issue 5, 1999, Pages 303-306

  Porta, Mauro ^a  

^a Pain Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; METHYLPREDNISOLONE;

CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ELECTROMYOGRAM; HUMAN; MYALGIA; NECK MUSCLE; PALPATION; PRESSURE MEASUREMENT; REVIEW; TENSION HEADACHE;

EID: 0032858823     PISSN: 09389016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Rasmussen BK, Jensen R, Schroll M et al: Epidemiology of headache in a general population - A prevalence study. J Clin Epidemiol 1991;44:1147-1157
2. Rasmussen BK: Epidemiology. In Olesen J, Tfelt-Hansen P, Welch KMA (eds): The Headaches. New York, Raven Press, 1993, pp 439-443
3. Schoenen J: Tension-type headache: Differential diagnosis. In Olesen J, Tfelt-Hansen P, Welch KMA (eds): The Headaches. New York, Raven Press, 1993, pp 509-510
4. Bogduk N: Anatomy and pathology. In Olesen J, Tfelt-Hansen P, Welch KMA (eds): The Headaches. New York, Raven Press, 1993, pp 445-454
5. International Headache Society Committee on Clinical Trials. Guidelines for trials of drug treatments in tension-type headache. First edition. Cephalalgia 1995;15:165-179
6. Drummond PD: Scalp tenderness and sensitivity to pain in migraine and tension headache. Headache 1987;27:45-50
7. Langemark M, Olesen J: Pericranial tenderness in tension headache. Cephalalgia 1987;7:249-255
8. Olesen J, Schoenen J: Synthesis. In Olesen J, Tfelt-Hansen P, Welch KMA (eds): The Headaches. New York, Raven Press, 1993, pp 493-496
9. Olesen J, Langemark M: Mechanisms of tension headache: A speculative hypothesis. In Olesen J, Edvinsson L (eds): Basic Mechanisms of Headache. Amsterdam, Elsevier, 1988, pp 457-461
10. Ohrbach R, Gale EN: Pressure pain threshold in normal muscles: Reliability, measurement effects, and topographic differences. Pain 1989;37:257-263
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96
12. Olesen J: Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal, and myofascial inputs. Pain 1991;46:125-132
13. Jensen R, Rasmussen BK, Pedersen B et al: Muscle tenderness and pressure pain thresholds in headache: A population study. Pain 1993;52: 193-199
14. Prichard DW: EMG cranial muscles levels in headache sufferers before and during headache. Headache 1989;29:103-108
15. Pfaffenrath V, Isler H: Evaluation of the nosology of chronic tension-type headache. Cephalalgia 1993;13(suppl 12):60-62
16. Merskey H, Bogduk N: Classification of Chronic Pain, ed 2. Seattle, IASP Press, 1994
17. Silberstein SD: Tension-type headaches. Headache 1994;34:S2-S7
18. Simons DG, Mense S: Understanding and measurement of muscle tone as related to clinical muscle pain. Pain 1998;75:1-17
19. Jensen K, Andersen H, Olesen J et al: Pressure pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain 1986;25:313-323
20. Jensen K, Jensen R: Myogenic nociception and pain thresholds. In Olesen J, Tfelt-Hansen P, Welch KMA (eds): The Headaches. New York, Raven Press, 1993, pp 227-231
21. Jensen R, Schoenen J: Pain thresholds. In Olesen J, Tfelt-Hansen P, Welch KMA (eds): The Headaches. New York, Raven Press, 1993, pp 483-487
22. Magni G: The use of antidepressants in the treatment of chronic pain: A review of the current evidence. Drugs 1991;42:730-748
23. Holroyd K: Behavioural treatment strategies. In Olesen J, Schoenen J (eds): Tension-type Headache: Classification, Mechanisms and Treatment. New York, Raven Press, 1993, pp 245-254
24. Acquadro M, Borodic G: Treatment of myofascial pain with botulinum A toxin. Anesthesiology 1994;80:705-706
25. Cheshire WP, Abashian SW, Mann JD: Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994;59:63-69
26. Porta M, Perretti A, Gamba M et al: Compartment botulinum toxin injection for myofascial pain relief. DOLOR 1997;12(suppl 1):42
27. Yue SK: Initial experience in the use of botulinum toxin A for the treatment of myofascial related muscle dysfunctions. J Musculoskeletal Pain 1995;3(suppl 1):22
28. Dykstra DD, Sidi AA, Scott AB et al: Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988;139:919-922
29. Schurch B, Hauri D, Rodic B et al: Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients. J Urol 1996;155:1023-1029
30. Relja M: Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997;4(suppl 2):S71-S73
31. Wheeler AH: Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998;38:468-471
32. Ahnert-Hilger G, Bigalke H: Molecular aspects of tetanus and botulinum neurotoxin poisoning. Prog Neurobiol 1995;46:83-96
33. Sjaastad O: So-called "tension-headache": A term in need of revision? Curr Med Res Opin 1980;8:41-44
34. Kudrow L: Muscle contraction headache. In Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology. Amsterdam, North Holland Publishing Company, 1986, pp 343-352
35. Zwart J-A, Bovim G, Sand T et al: Tension headache: Botulinum toxin paralysis of temporal muscles. Headache 1994;34:458-462
36. Gordh T, Karlsten R, Kristensen J: Intervention with spinal NMDA, adenosine and NO systems for pain modulation. Ann Med 1995;27:229-234
37. Choi Y, Raja SN, Moore LC et al:. Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue. J Neurol Sci 1996;138:14-20